DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Georgoulias V, Bozionelou V, Agelaki S et al.
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19 mRNA-positive circulating tumor cells: results of a randomized phase II study.
Ann Oncol 2012;
23: 1744-1750
We do not assume any responsibility for the contents of the web pages of other providers.